Atlas.
Sign inStart free trial
GKOSNASDAQ · US

GLAUKOS Corp

Technology · Surgical & Medical Instruments & Apparatus

TechnologySurgical & Medical Instruments & Apparatus
CEO
Thomas W. Burns
Founded
IPO Date
HQ
Aliso Viejo, CA, United States
Exchange
NYSE
Employees
n.a.

Share Price Performance

$137.57 24.3%
Last (1 Jul 2026) · $138
Period High · $144.42
Period Low · $97.02
52W: $74.67$144.42

Key Metrics

Share Price
$137.57
-1.6% today
Market Cap
$7.9B
P / E
EV / Revenue
15.4x
Revenue Growth
+32.3%
year-on-year
Gross Margin
+55.7%
Enterprise Value
$7.8B
52W High
$144.42
52W Low
$74.67
Avg Volume
873K
daily

Sources: SEC filings · Market data as of Jul 6, 2026

Shareholders' Structure
13 known institutional holders·$1.9B total on record·2026-Q1
BlackRock, Inc.
15.8%·$979M
State Street Corp
3.8%·$235M
Goldman Sachs Group Inc
2.4%·$148M
Geode Capital Management, LLC
2.4%·$146M
Invesco Ltd.
1.6%·$98M
Bank Of America Corp
1.1%·$71M
Northern Trust Corp
1.0%·$62M
Price T Rowe Associates Inc
0.6%·$36,221
Jpmorgan Chase & Co
0.6%·$34M
Fmr LLC
0.5%·$33M
Dimensional Fund Advisors LP
0.3%·$21M
Renaissance Technologies LLC
0.2%·$13M
Point72 Asset Management, L.P.
0.2%·$11M
Free Float
69.5%

Sources: SEC filings

Notes: % shown as share of total shares outstanding · Free float = shares outstanding minus all known 13F institutional holdings

What Atlas covers for GLAUKOS Corp
OverviewGLAUKOS Corp share price history (10 years), key market statistics, and institutional shareholder structure from SEC 13F-HR filings.Business ModelHow GLAUKOS Corp generates revenue — product and service segments, geographic breakdown, key operating metrics, and 10-year business evolution sourced from SEC filings.FinancialsGLAUKOS Corp's complete financial history — 10 years of annual revenue, gross margins, operating income, net income, EPS, and free cash flow from SEC filings, plus 12 quarters of quarterly results.Management QualityGLAUKOS Corp executive team profiles, insider buying and selling from SEC Form 4, earnings call transcripts, and a track record of guidance delivery vs actual results.Risk FactorsGLAUKOS Corp's annual risk disclosures from SEC filings — full text, 5-year evolution showing how risks have shifted, and year-on-year delta highlighting new and removed risks.NewsAI-synthesised news digest for GLAUKOS Corp, updated regularly with key developments, earnings updates, product announcements, and material company events.SentimentInvestor sentiment for GLAUKOS Corp aggregated from X.com, Reddit, and Hacker News — discussion themes, Bull and Bear signals, and community analysis.Valuation & PeersGLAUKOS Corp valuation multiples — P/E, EV/Revenue, EV/EBITDA — compared against a curated set of industry peers using live data from SEC filings. Custom peer selection available.DCF BuilderBuild a discounted cash flow model for GLAUKOS Corp with 10 years of pre-filled revenue, margins, and cash flow data from SEC filings. Adjust growth rates, WACC, and terminal assumptions.Atlas AnalysisAtlas AI research synthesis for GLAUKOS Corp — business model, financial health, management quality, risk profile, and institutional ownership, grounded exclusively in SEC filings.

Unlock the full analysis

9-tab institutional research sourced directly from SEC filings. No tips, no scores — the same process professional investors use.

7-day free trial · Plus & Pro · No charge during trial